AT&T (T) looks attractive for dividend investors: buybacks up to $20B by 2027 and DDM fair value $16–$33. See here for more ...
AbbVie reported mixed Q2 2024 results, adding to my concerns of its growth potential. Looking ahead, I see continued pressure for Humira sales and also increasing in-house R&D expenses. These issues ...
If you are wondering whether Fermi's current share price lines up with its underlying worth, you are not alone. This article is built to help you frame that question clearly. Fermi's share price last ...
Investors buy stocks to participate in the growth of a company. Many stocks reward investors with dividend payments, but how do you know whether you’re paying more for a stock than what it is worth?
If you are wondering whether Ørsted’s current share price still reflects its long term potential, you are not alone. Many investors are asking the same question right now. The stock has been volatile, ...
Most Wall Street "suits" are allergic to dividend cuts. These spreadsheet jockeys sooooo lack imagination. They prefer linear trends--up and to the right. Dividend growers model nicely. Payout "resets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results